Phillip K. Pellitteri
Geisinger Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Phillip K. Pellitteri.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1997
Phillip K. Pellitteri; K. Thomas Robbins; Thomas R. Neuman
The efficacy of extending the application of selective neck dissection to include more‐extensive neck disease in patients with squamous carcinoma of the upper aerodigestive tract remains controversial.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2013
Primož Strojan; Alfio Ferlito; Jesus E. Medina; Julia A. Woolgar; Alessandra Rinaldo; K. Thomas Robbins; Johannes J. Fagan; William M. Mendenhall; Vinidh Paleri; Carl E. Silver; Kerry D. Olsen; June Corry; Carlos Suárez; Juan P. Rodrigo; Johannes A. Langendijk; Kenneth O. Devaney; Luiz Paulo Kowalski; Dana M. Hartl; Missak Haigentz; Jochen A. Werner; Phillip K. Pellitteri; Remco de Bree; Gregory T. Wolf; Robert P. Takes; Eric M. Genden; Michael L. Hinni; Vanni Mondin; Ashok R. Shaha; Leon Barnes
In an era of advanced diagnostics, metastasis to cervical lymph nodes from an occult primary tumor is a rare clinical entity and accounts for approximately 3% of head and neck malignancies. Histologically, two thirds of cases are squamous cell carcinomas (SCCs), with other tissue types less common in the neck. With modern imaging and tissue examinations, a primary tumor initially undetected on physical examination is revealed in >50% of patients and the site of the index primary can be predicted with a high level of probability. In the present review, the range and limitations of diagnostic procedures are summarized and the optimal diagnostic workup is proposed. Initial preferred diagnostic procedures are a fine‐needle aspiration biopsy (FNAB) and imaging. This allows directed surgical biopsy (such as tonsillectomy), based on the preliminary findings, and prevents misinterpretation of postsurgical images. When no primary lesion is suggested after imaging and panendoscopy, and for patients without a history of smoking and alcohol abuse, molecular profiling of an FNAB sample for human papillomavirus (HPV) and/or Epstein–Barr virus (EBV) is important. Head Neck, 2013
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2013
Carlos Suárez; Juan P. Rodrigo; Carsten C. Bödeker; José Luis Llorente; Carl E. Silver; Jeroen C. Jansen; Robert P. Takes; Primoẑ Strojan; Phillip K. Pellitteri; Alessandra Rinaldo; William M. Mendenhall; Alfio Ferlito
The definitive treatment for head and neck paraganglioma (PG) is surgical excision. Unfortunately, surgery, particularly of vagal paraganglioma (VPG; “glomus vagale”) and foramen jugulare (“glomus jugulare”) tumors, may be complicated by injuries to the lower cranial nerves, a high price to pay for treatment for a benign tumor. Alternatively these tumors may be followed without treatment, or irradiated. The purpose of this review was to compare the existing evidence concerning the efficacy and safety of surgery, external beam radiotherapy (EBRT), and stereotactic radiosurgery (SRS), for jugular paragangliomas (JPGs) and VPGs.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2006
Phillip K. Pellitteri; Alfio Ferlito; Alessandra Rinaldo; Jatin P. Shah; Randal S. Weber; John Lowry; Jesus E. Medina; Christine G. Gourin; K. Thomas Robbins; Carlos Suárez; Ashok R. Shaha; Eric M. Genden; C. René Leemans; Jean-Louis Lefebvre; Luiz Paulo Kowalski; William I. Wel
In the absence of large‐scale randomized trials evaluating dissection versus observation of the involved neck after neoadjuvant chemoradiotherapy, there is a need to collect data that will either support or ultimately refute a role for planned posttreatment neck dissection. A significant percentage of patients with extensive (N2 or N3) neck disease who demonstrate a complete response to chemoradiation therapy may harbor residual occult metastases, and identification of this subset of patients remains a clinical challenge. Because surgical salvage rates are greatly diminished when occult nodal disease becomes clinically manifest, planned posttreatment neck dissection is advocated but may not be necessary in all patients. The role of positron emission tomography chemoradiotherapy (PET‐CT) in this scenario remains unproven but holds promise in being able to identify which patients may be harboring residual disease in the neck after chemoradiotherapy. The implementation of as yet unidentified molecular tumor markers in combination with PET‐CT may ultimately prove to be effective in identifying patients who will best benefit from posttherapy neck dissection. Correlation of imaging results and pathologic node status will be important in determining the accuracy and, therefore, the value of this imaging modality for predicting the presence or absence of residual disease.
Oral Oncology | 2003
Phillip K. Pellitteri; Alfio Ferlito; Patrick J. Bradley; Ashok R. Shaha; Alessandra Rinaldo
Sarcomas account for less than 1% of all malignant neoplasms occurring in the head and neck in adults. These tumors exhibit variable growth and degrees of aggressiveness which are primarily dependent on histologic grade. The pattern of growth demonstrated by sarcomas is generally by local advancement with high-grade tumor exhibiting extensive involvement of adjacent visceral and neurovascular structures. Regional metastasis is uncommon. Etiologic considerations include the tumorigenic effects of prior external beam radiotherapy and the development of second malignancies in the form of sarcomas. The clinical presentation of these neoplasms is variable and dependent on subsite of involvement as well as the aggressiveness of tumor growth. Histologic diagnosis is frequently challenging, often requiring the aid of immunohistochemical staining techniques. Treatment is predominantly surgical, utilizing wide local excision where en-bloc resection is feasible. Radiotherapy, by means of external beam or implant, plays an important adjunctive role in management, especially for tumors where en-bloc resection with margin control is not possible. Chemotherapy regimens are available for soft tissue neoplasms and osteosarcoma and are primarily designed to improve local control. Survival is predicted on the incidence of local recurrence and risk of distant metastasis, both of which are influenced by tumor grade. Low-grade tumors exhibit improved survival over that of less differentiated tumors.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2013
Primož Strojan; Alfio Ferlito; Johannes A. Langendijk; June Corry; Julia A. Woolgar; Alessandra Rinaldo; Carl E. Silver; Vinidh Paleri; Johannes J. Fagan; Phillip K. Pellitteri; Missak Haigentz; Carlos Suárez; K. Thomas Robbins; Juan P. Rodrigo; Kerry D. Olsen; Michael L. Hinni; Jochen A. Werner; Vanni Mondin; Luiz Paulo Kowalski; Kenneth O. Devaney; Remco de Bree; Robert P. Takes; Gregory T. Wolf; Ashok R. Shaha; Eric M. Genden; Leon Barnes
Although uncommon, cancer of an unknown primary (CUP) metastatic to cervical lymph nodes poses a range of dilemmas relating to optimal treatment. The ideal resolution would be a properly designed prospective randomized trial, but it is unlikely that this will ever be conducted in this group of patients. Accordingly, knowledge gained from retrospective studies and experience from treating patients with known head and neck primary tumors form the basis of therapeutic strategies in CUP. This review provides a critical appraisal of various treatment approaches described in the literature. Emerging treatment options for CUP with metastases to cervical lymph nodes are discussed in view of recent innovations in the field of head and neck oncology and suitable therapeutic strategies for particular clinical scenarios are presented. For pN1 or cN1 disease without extracapsular extension (ECE), selective neck dissection or radiotherapy offer high rates of regional control. For more advanced neck disease, intensive combined treatment is required, either a combination of neck dissection and radiotherapy, or initial (chemo)radiotherapy followed by neck dissection if a complete response is not recorded on imaging. Each of these approaches seems to be equally effective. Use of extensive bilateral neck/mucosal irradiation must be weighed against toxicity, availability of close follow‐up with elective neck imaging and guided fine‐needle aspiration biopsy (FNAB) when appropriate, the human papillomavirus (HPV) status of the tumor, and particularly against the distribution pattern (oropharynx in the majority of cases) and the emergence rate of hidden primary lesions (<10% after comprehensive workup). The addition of systemic agents is expected to yield similar improvement in outcome as has been observed for known head and neck primary tumors. Head Neck, 2013
Modern Pathology | 2005
Ping L. Zhang; Phillip K. Pellitteri; Amy Law; Patricia A. Gilroy; G. Craig Wood; Thomas L. Kennedy; Thomas M. Blasick; Mingyue Lun; Conrad Schuerch; Robert E. Brown
Intracellular signals along the epidermal growth factor receptor (EGFR)–Akt–nuclear factor-kappa B (NF-κB) pathway have been associated with carcinogenesis in various malignant neoplasms. This investigation was to evaluate the expression of EGFR, phosphorylated(p)-Akt and p-NF-κB and correlate them with clinical outcomes in patients with squamous cell carcinoma of the tonsil. A total of 45 patients with squamous cell carcinoma of the tonsil were studied by immunohistochemistry to evaluate the expression levels of EGFR, p-Akt and p-NF-κB. Results for squamous cell carcinoma of the tonsil were compared with those for associated high-grade dysplasia and adjacent normal appearing epithelium, when present. In addition, tonsillar epithelium from non-neoplastic specimens of age-matched patients also was stained for the same markers. High-grade dysplasia and squamous cell carcinoma of the tonsil demonstrated a similar pattern of expression, which differed from the pattern seen in the adjacent normal epithelium and tonsillar epithelium from normal controls (an overexpression for each of these three protein analytes in high-grade dysplasia and squamous cell carcinoma of the tonsil as demonstrated by immunohistochemistry). When markers from squamous cell carcinoma of the tonsil were correlated with survival status, only increasing levels of p-NF-κB immunoreactivity (a relative overexpression) were statistically significant predictors of poor survival. No markers in squamous cell carcinoma of the tonsil were significantly related to rate of recurrence. When analyzing marker scores from tissue with high-grade dysplasia, relative overexpressions of both p-Akt and p-NF-κB were significantly related to poor survival. Additionally, increasing levels of p-NF-κB immunopositivity from tissue with high-grade dysplasia were also significantly related to rate of recurrence. In summary, p-NF-κB, overexpressed in high-grade dysplasia and squamous cell carcinoma of the tonsil, is associated with worse prognosis in terms of high recurrence and poor survival, respectively. This significant finding in patients with squamous cell carcinoma of the tonsil, in combination with previous animal and in vitro studies, suggests that p-NF-κB represents a potential therapeutic target in head and neck squamous cell carcinoma.
Acta Oto-laryngologica | 2004
Simon N. Rogers; Alfio Ferlito; Phillip K. Pellitteri; Ashok R. Shaha; Alessandra Rinaldo
SIMON N. ROGERS, ALFIO FERLITO, PHILLIP K. PELLITTERI, ASHOK R. SHAHA and ALESSANDRA RINALDO From the Department of Oral and Maxillofacial Surgery, University Hospital Aintree and Liverpool University Dental Hospital, Liverpool, UK, the Departments of Otolaryngology /Head and Neck Surgery, University of Udine, Udine, Italy and Geisinger Medical Center, Danville, Philadelphia, USA and the Head and Neck Service, Memorial Sloan /Kettering Cancer Center, New York, New York, USA
Journal of The American College of Surgeons | 2001
K. Thomas Robbins; John L. D. Atkinson; Robert M. Byers; James I. Cohen; Pierre Lavertu; Phillip K. Pellitteri
Management of the Carotid Artery in Neck Dissection Neck dissection, or cervical lymphadenectomy, is a time-honored procedure used to treat metastastic carcinoma to the neck. Under most circumstances, the site of origin lies within the upper aerodigestive tract, thyroid gland, salivary glands, or the surrounding cutaneous structures. Contemporary approaches to neck surgery have included modifications of the classical radical neck dissection involving preservation of certain lymphatic regions, sparing nonlymphatic structures, or in some situations, removal of additional structures. As other modalities are proving to be effective treatment strategies for metastatic neck cancer, there is also a pressing need to define the role of neck dissection as part of a multimodality approach. Given this evolving role of neck dissection, this article is intended to outline the use and, in some situations, the misuse of these procedures in the management of patients with head and neck carcinoma. We served as panelists when this topic was presented at the annual meeting of the American College of Surgeons, October 2000.
Laryngoscope | 2014
Vinidh Paleri; Michael Drinnan; Michiel W. M. van den Brekel; Michael L. Hinni; Patrick J. Bradley; Gregory T. Wolf; Remco de Bree; Johannes J. Fagan; Marc Hamoir; Primož Strojan; Juan P. Rodrigo; Kerry D. Olsen; Phillip K. Pellitteri; Ashok R. Shaha; Eric M. Genden; Carl E. Silver; Carlos Suárez; Robert P. Takes; Alessandra Rinaldo; Alfio Ferlito
Pharyngocutaneous fistulae (PCF) are known to occur in nearly one‐third of patients after salvage total laryngectomy (STL). PCF has severe impact on duration of admission and costs and quality of life and can even cause severe complications such as bleeding, infection and death. Many patients need further surgical procedures. The implications for functional outcome and survival are less clear. Several studies have shown that using vascularized tissue from outside the radiation field reduces the risk of PCFs following STL. This review and meta‐analysis aims to identify the evidence base to support this hypothesis.